Latest New Drug Application Stories
The First, Once-Daily, Extended-Release Amphetamine-based Oral Liquid for the Treatment of ADHD MONMOUTH JUNCTION, N.J., May 21, 2015 /PRNewswire/ -- Tris Pharma, Inc.
ROCKVILLE, Md., May 15, 2015 /PRNewswire/ -- TissueGene, Inc. announced today that it has reached an agreement with the U.S.
LYNDHURST, N.J., April 30, 2015 /PRNewswire/ -- Amerigen Pharmaceuticals Limited today announced that the U.S.
BUENA, N.J., April 28, 2015 /PRNewswire/ -- IGI Laboratories, Inc.
LYNDHURST, N.J., April 17, 2015 /PRNewswire/ -- Amerigen Pharmaceuticals Limited today announced that the U.S.
-- New Drug Application for once-daily formulation of lorcaserin expected to be submitted to the FDA later this year -- WOODCLIFF LAKE, N.J.
LEXINGTON, Massachusetts, April 9, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has
DUBLIN, April 3, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
SHANGHAI, March 27, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc.
BUENA, N.J., March 26, 2015 /PRNewswire/ -- IGI Laboratories, Inc.
- A handkerchief.
- In general, any miraculous portrait of Christ.